If you want to perform research with material from a biobank and the initiation of this biobank has already been approved by the CMO Radboudumc, you only need to submit an application to the CMO Radboudumc for assessment in certain cases, namely:
- The material will be used for research that does not fit the objectives of the biobank and the informed consent of the donors.
- The material will be used for research with a chance of new findings regarding the (future) health status of individual donors and/or relatives; donors have consented to being informed, where appropriate, of new findings that might occur.
- In research:
- material will be used that has been obtained from donors under the age of 16 or from incapacitated donors;
- material will be used when the donors in question have reached the age of 16 or it is likely that the donors in question are no longer incapacitated;
- the donors in question have not given a reconsideration to participate in the biobank.
More information can be found here.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Dutch-Nordic Alliance for Precision Cancer Medicine launched26 November 2021
The Nordic countries (Denmark, Sweden, Norway, and Finland) are together setting up national clinical precision cancer trials modelled on the very successful DRUP trial in the Netherlands.read more
New Automated PBMC isolation method introduced in LMI.21 September 2021
The Radboud Biobank (RB) and the laboratory of Medical Immunology (LMI) are making plans to replace the density gradient centrifugation method with a new automated PBMC isolation method, the AutoMACS Pro Separator.read more
Lysine Metabolism sub-biobank21 September 2021
Hereditary metabolic disorders form a large group of more than 1,400 rare disorders in which an error in the DNA causes abnormalities in the process in which proteins, fats and carbohydrates are converted into smaller building materials and energy.read more